查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1470855

再生醫學市場：按類型和應用分類－2024年至2030年全球預測

Regenerative Medicine Market by Type (Cell-Based Immunotherapy & Cell Therapy Products, Gene Therapy Products, Small Molecule & Biologic), Application (Cardiovascular, Diabetes, Musculoskeletal Disorders) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年再生醫學市場規模為230.2億美元，預計2024年將達283.5億美元，2030年將達到1,024億美元，複合年成長率為23.76%。

再生醫學是一個跨學科領域，應用工程和生命科學原理來促進細胞、組織和器官的再生、修復和替換。我們的目標是透過結合多種方法來恢復受損和患病組織的功能，包括細胞治療、基因治療、組織工程以及生物材料和生長因子的應用。這個快速發展的領域有望透過利用人體自身的修復機製或在實驗室中創建功能組織來治療各種醫療狀況。再生醫學市場的促進因素包括慢性病和遺傳疾病的日益普及、細胞療法和組織工程的進步以及對研發的重大投資導致突破性治療方法。此外，世界人口老化和對創新再生治療的需求也有助於市場擴張。然而，他們面臨一些障礙，例如嚴格的監管政策減緩了核准流程、治療和研究相關的高成本以及幹細胞使用的倫理問題。此外，個人化醫療的進步正在擴大客製化治療的可能性。新興市場也提供了新的擴張途徑，技術創新不斷帶來更好的治療效果，最終可能導致治療成本降低。

主要市場統計
基準年[2023] 230.2億美元
預測年份 [2024] 283.5億美元
預測年份 [2030] 1024億美元
複合年成長率（%） 23.76%

細胞免疫療法和細胞治療產品在個人化治療的重要應用

再生醫學正在透過基於細胞的免疫療法和細胞治療產品徹底改變治療領域。這些先進的治療方法利用細胞來治療疾病，包括取自捐贈者並給予多名患者的異體產品，以及取自同一個人並用於治療的自製產品。基因治療產品代表了再生醫學的重要組成部分，其重點是直接操縱生物體的基因來治療或預防疾病。這些治療方法透過引入、移除或改變患者細胞內的遺傳物質來糾正遺傳異常、表達治療性蛋白質或禁用故障基因。再生醫學的大類包括小分子藥物和生技藥品。小分子通常是可以調節生物過程的明確的小分子化合物，而生技藥品涵蓋多種產品，例如抗體、重組蛋白和胜肽。這些藥物通常透過影響細胞路徑來刺激或誘導再生過程，使它們在修復複雜的組織和器官方面特別有效。組織工程產品開發是再生醫學的一個變革領域，旨在修復、替換、維護和增強人體組織。利用支架、細胞和生物活性分子的組織工程方法透過精心設計可與患者組織整合的結構，為器官短缺提供了解決方案，使其比傳統移植和重組手術的效果低。

再生醫學在應用心血管疾病的重要性日益增加

再生醫學透過細胞療法、組織工程和基因編輯來修復或替換受損的心臟組織，為心血管疾病提供潛在的治療方法。再生醫學在心臟病學中的普及主要是因為它能夠最大限度地減少侵入性手術，並有望在心臟衰竭和周邊動脈疾病等疾病中實現長期康復。糖尿病影響著全世界數百萬人，再生醫學透過恢復產生胰島素的BETA細胞和再生胰臟組織提供了治療的潛力。 1 型糖尿病尤其需要這種創新治療方法，因為自體免疫反應會破壞 BETA 細胞，並要求患者終生接受胰島素治療。肌肉骨骼疾病包括影響骨骼、肌肉和結締組織的多種疾病。軟骨再生和骨骼修復等再生醫學應用解決了在損傷後以及骨關節炎等退化性疾病中縮短癒合時間和功能恢復的巨大需求。此外，再生醫學可以提供基於細胞的治療方法和組織工程解決方案，以恢復視力並阻止疾病進展和其他眼科疾病。腫瘤學是再生醫學有可能徹底改變癌症治療的重要領域。透過利用人體自身的治癒機制，它可以刺激免疫系統瞄準並摧毀癌細胞。由於與傳統治療方法相比，此類治療方法具有個人化性質且副作用較少，因此越來越受到青睞。傷口護理也是醫療保健的重要組成部分，特別是對於因糖尿病或血管疾病而導致癒合受損的患者。再生醫學領域正在解決透過開發生物工程組織和生長因子來更快、更有效地促進慢性和急性傷口癒合的治療方法需求。

區域洞察

由於廣泛的研發活動、強勁的金融投資以及政府對再生醫學及相關治療的支持政策，美洲的再生醫學市場呈現顯著成長。生物技術和製藥領域領先公司的存在，以及組織工程和幹細胞治療的技術進步，正在促進該地區市場的強勁擴張。在強大的醫療保健系統和對再生治療方案認知不斷提高的支持下，歐洲、中東和非洲 (EMEA) 地區擴大採用再生醫學。對幹細胞研究和基因治療的大量投資以及再生醫學產品臨床試驗的激增進一步推動了歐洲市場的成長。由於投資和研究合作的增加，中東和非洲也逐漸增加在市場上的影響力。由於積極的政府措施、醫療成本的上升以及尋求先進治療的患者數量的增加，亞太地區 (APAC) 的市場正在快速擴張。該地區再生醫學產品研究和製造設施數量的不斷增加也推動了亞太地區市場的積極前景。

FPNV定位矩陣

FPNV定位矩陣對於評估再生醫學市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對再生醫學市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴見解，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

本報告在以下方面提供了寶貴的見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓：我們深入研究利潤豐厚的新興市場，並分析其在成熟細分市場的滲透率。

3. 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4. 競爭評估和情報：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況和製造能力進行全面評估。

5. 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1.再生醫學市場的市場規模和預測是多少？

2.再生醫學市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3.再生醫學市場的技術趨勢和法規結構是什麼？

4.再生醫學市場主要廠商的市場佔有率是多少？

5.進入再生醫學市場的合適形式和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 更多採用幹細胞技術、基因治療和組織工程
      • 政府加大對再生醫學研究的投資
      • 產品核可以及私人公司研發活動的增加
    • 抑制因素
      • 與幹細胞和再生醫學相關的高成本和監管問題
    • 機會
      • 再生醫學生技藥品的技術進步
      • 對器官和骨移植的需求增加
    • 任務
      • 有關在研究和開發中使用胚胎幹細胞的倫理問題
  • 市場區隔分析
    • 類型：細胞免疫療法和細胞治療產品在個人化治療中的重要應用
    • 應用：再生醫學在心血管疾病的重要性日益增加
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章再生醫學市場：依類型

  • 基於細胞的免疫療法和細胞治療產品
  • 基因治療產品
  • 小分子/生技藥品
  • 組織工程產品

第7章再生醫學市場：依應用分類

  • 心血管
  • 糖尿病
  • 肌肉骨骼疾病
  • 眼科疾病
  • 腫瘤學
  • 創傷護理

第8章 北美和南美再生醫學市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章 亞太再生醫學市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東、非洲再生醫學市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 4DMT 的 4D-150 獲得 FDA 的高級治療指定，這是一種用於玻璃體內治療濕性 AMD 的基因藥物。
    • Sysmex 和 JCR Pharma 的合資企業 Allied Cell 收購了一條新的管道，以促進再生醫療產品的早期社會實施
    • 西乃山建立再生醫學研究所
  • 戰略分析和建議

第12章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-430D42AA0F5B

[197 Pages Report] The Regenerative Medicine Market size was estimated at USD 23.02 billion in 2023 and expected to reach USD 28.35 billion in 2024, at a CAGR 23.76% to reach USD 102.40 billion by 2030.

Regenerative medicine is an interdisciplinary field that applies engineering and life science principles to promote regeneration, repair, or replacement of cells, tissues, or organs. It aims to restore the function of damaged or diseased tissues using a combination of approaches, including cell therapy, gene therapy, tissue engineering, and the application of biomaterials and growth factors. This rapidly evolving field holds the promise for treating various medical conditions by harnessing the body's own repair mechanisms or by creating functional tissues in the laboratory. The market for regenerative medicine is propelled by factors such as the increasing prevalence of chronic diseases and genetic disorders, advances in cellular therapy and tissue engineering, and significant investments in research and development that lead to breakthrough therapies. Additionally, the aging global population and its need for innovative regenerative treatments contribute to the expansion of the market. However, regenerative medicine faces obstacles, including stringent regulatory policies that slow down approval processes, high costs associated with therapies and research, and ethical concerns regarding stem cell use. Moreover, personalized medicine advancements open up possibilities for tailored treatments. Emerging markets are also providing new avenues for expansion, and technological innovations continue to enable better outcomes and potentially lower treatment costs over time.

KEY MARKET STATISTICS
Base Year [2023] USD 23.02 billion
Estimated Year [2024] USD 28.35 billion
Forecast Year [2030] USD 102.40 billion
CAGR (%) 23.76%

Type: Significant applications of cell-based immunotherapies and cell therapy products in personalized treatment

Regenerative medicine is revolutionizing the therapeutic landscape with cell-based immunotherapy and cell therapy products. These advanced therapies involve using cells to treat diseases, with allogeneic products derived from a donor and administered to multiple patients and autologous products, which are harvested from and used to treat the same individual. Gene therapy products epitomize a significant component of regenerative medicine, focusing on the direct manipulation of an organism's genes to treat or prevent disease. These therapies work by introducing, removing, or altering genetic material within a patient's cells, thereby providing a means to correct genetic abnormalities, expressing therapeutic proteins, or disabling malfunctioning genes, and have shown immense potential in the treatment of genetic disorders, certain types of cancer, and viral infections. A broad category within regenerative medicine includes small molecule and biologics. Small molecules are typically well-defined, low molecular weight compounds that can modulate biological processes, while biologics encompass a range of products such as antibodies, recombinant proteins, and peptides. These agents often act to stimulate or guide the regeneration process by influencing cellular pathways and can be particularly effective in complex tissue and organ repair. The development of tissue-engineered products is a transformative area within regenerative medicine aimed at repairing, replacing, maintaining, or enhancing the function of human tissues. Utilizing scaffolds, cells, and biologically active molecules, tissue engineering approaches meticulously design constructs that can integrate with patient tissues, offering solutions for organ shortages and providing alternatives to traditional transplants and reconstructive surgeries.

Application: Growing significance of regenerative medicines for cardiovascular diseases

Regenerative medicine offers potential treatments for cardiovascular diseases through cell therapy, tissue engineering, and gene editing to repair or replace damaged heart tissue. Preference for regenerative medicine in cardiology primarily stems from its ability to minimize invasive procedures and its promise for long-term recovery in conditions including heart failure and peripheral artery disease. Diabetes affects millions worldwide, and regenerative medicine offers the possibility of restoring insulin-producing beta cells or regenerating pancreatic tissue to treat it. There is a strong need for such innovative treatments, particularly for type 1 diabetes, where autoimmune responses destroy beta cells, and patients require lifelong insulin therapy. Musculoskeletal disorders include a wide range of conditions affecting bones, muscles, and connective tissue. Regenerative medicine applications, such as cartilage regeneration and bone repair, address the tremendous need for improved healing times and functional recovery post-injury or in the case of degenerative diseases, including osteoarthritis. Moreover, regenerative medicine can provide cell-based therapies and tissue engineering solutions to restore sight or halt disease progression and other ocular disorders. Oncology is a critical area where regenerative medicine can potentially revolutionize cancer treatment. By leveraging the body's own healing mechanisms, it can stimulate the immune system to target and destroy cancer cells. There is an increasing preference for these treatments owing to their personalized nature and their potential for fewer side effects compared to traditional therapies. Wound care is another essential component of healthcare, particularly for patients with diabetes or vascular diseases that impair healing. The field of regenerative medicine, through the development of bioengineered tissues and growth factors, addresses the need for therapies that promote faster and more effective healing of chronic and acute wounds.

Regional Insights

The regenerative medicine market in the Americas has shown significant growth with extensive research and development activities, strong financial investments, and supportive government policies for regenerative medicine and related therapies. The presence of significant players in the biotechnology and pharmaceutical sectors, coupled with technological advancements in tissue engineering and stem cell therapy, has contributed to the robust expansion of the market in this region. Europe, the Middle East, and Africa (EMEA) region exhibit a progressive adoption of regenerative medicine, backed by strong healthcare systems and rising awareness of regenerative treatment options. Europe, with substantial investments in stem cell research and gene therapy and the upsurge in clinical trials for regenerative products, has further fueled the market growth. The Middle East and Africa are also gradually expanding their market presence with increasing investments and collaborations. The Asia-Pacific (APAC) region has illustrated rapid market expansion with favorable government initiatives, rising healthcare expenditure, and a growing patient population looking for advanced treatments. The increasing number of research facilities and manufacturing units for regenerative products in this region adds to the positive outlook of the APAC market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Regenerative Medicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Regenerative Medicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include 4D Molecular Therapeutics, Inc., Allergan PLC, Amgen Inc., Astellas Pharma Inc., Athersys, Inc., Bayer AG, CMIC HOLDINGS Co., LTD., Editas Medicine, Inc., FUJIFILM Cellular Dynamics, Inc., Gilead Sciences, Inc., Integra LifeSciences Holdings Corporation, JCR Pharmaceuticals Co., Ltd., Medtronic PLC, Mimedx Group, Novartis AG, Organogenesis Inc., Osiris Therapeutics, Inc. by Smith & Nephew PLC, REPROCELL Inc., SanBio Company Limited, Sartorius AG, Sumitomo Pharma Co., Ltd., Sysmex Corporation, Takeda Pharmaceutical Co. Ltd., Tenaya Therapeutics, Inc., Vericel Corporation, Wright Medical Group N.V., and Zimmer Biomet Holdings Inc..

Market Segmentation & Coverage

This research report categorizes the Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Cell-Based Immunotherapy & Cell Therapy Products
      • Allogeneic Products
      • Autologous Products
    • Gene Therapy Products
    • Small Molecule & Biologic
    • Tissue-Engineered Products
  • Application
    • Cardiovascular
    • Diabetes
    • Musculoskeletal Disorders
    • Ocular Disorders
    • Oncology
    • Wound Care
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Regenerative Medicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Regenerative Medicine Market?

3. What are the technology trends and regulatory frameworks in the Regenerative Medicine Market?

4. What is the market share of the leading vendors in the Regenerative Medicine Market?

5. Which modes and strategic moves are suitable for entering the Regenerative Medicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing adoption of stem cell technologies, gene therapies, and tissue engineering
      • 5.1.1.2. Rising government investments in regenerative medicine research
      • 5.1.1.3. Product approval coupled with increasing R&D activities by private players
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and regulatory issues pertaining to stem cell and regenerative medicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in regenerative medicine biologics
      • 5.1.3.2. Growing demand for organ transplantation and bone grafting
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues related to the use of embryonic stem cells in R&D
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Significant applications of cell-based immunotherapies and cell therapy products in personalized treatment
    • 5.2.2. Application: Growing significance of regenerative medicines for cardiovascular diseases
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Regenerative Medicine Market, by Type

  • 6.1. Introduction
  • 6.2. Cell-Based Immunotherapy & Cell Therapy Products
  • 6.3. Gene Therapy Products
  • 6.4. Small Molecule & Biologic
  • 6.5. Tissue-Engineered Products

7. Regenerative Medicine Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular
  • 7.3. Diabetes
  • 7.4. Musculoskeletal Disorders
  • 7.5. Ocular Disorders
  • 7.6. Oncology
  • 7.7. Wound Care

8. Americas Regenerative Medicine Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Regenerative Medicine Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Regenerative Medicine Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. 4DMT Receives FDA Regenerative Medicine Advanced Therapy Designation for 4D-150 Genetic Medicine for Intravitreal Treatment of Wet AMD
    • 11.3.2. AlliedCel, a Joint Venture Between Sysmex and JCR Pharmaceuticals, Has Acquired a New Pipeline to Promote the Early Social Implementation of Regenerative Medicine Products
    • 11.3.3. Mount Sinai Launches Institute for Regenerative Medicine
  • 11.4. Strategy Analysis & Recommendation

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. REGENERATIVE MEDICINE MARKET DYNAMICS
  • FIGURE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ALLOGENEIC PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY AUTOLOGOUS PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE & BIOLOGIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY SMALL MOLECULE & BIOLOGIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE-ENGINEERED PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY MUSCULOSKELETAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY OCULAR DISORDERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL REGENERATIVE MEDICINE MARKET SIZE, BY WOUND CARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY CELL-BASED IMMUNOTHERAPY & CELL THERAPY PRODUCTS, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 291. REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023